NL
IRMD icon

NKCFO LLC’s iRadimed IRMD Stock Holding History

NKCFO LLC’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$165K Buy
1,725
+935
+118% +$85.2K 0.05% 71
2026
Q1 		$76K Hold
790
– – 0.02% 99
2025
Q4 		$77K Sell
790
-560
-41% -$48K 0.02% 85
2025
Q3 		$96K Buy
+1,350
New +$90K 0.03% 92
2019
Q2 		– Sell
-3,550
Closed -$100K – 114
2019
Q1 		$100K Hold
3,550
– – 0.07% 76
2018
Q4 		$87K Buy
+3,550
New +$95.4K 0.07% 65

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NKCFO LLC's IRMD Position: Q2 2026 in Review

NKCFO LLC increased its iRadimed (IRMD) stake by 118% in Q2 2026, buying an estimated $85.2K and bringing the position to 1,725 shares worth $165K. The position accounts for 0.05% of the portfolio, ranked #71.

NKCFO LLC first reported a position in IRMD in Q4 2018 and has held it in 6 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • NKCFO LLC held 1,725 shares of iRadimed worth $165K as of Q2 2026.
  • NKCFO LLC bought 935 iRadimed shares in Q2 2026, an estimated $85.2K.
  • iRadimed made up 0.05% of NKCFO LLC's portfolio in Q2 2026, its #71 holding.
  • NKCFO LLC first reported a position in iRadimed in Q4 2018 and has held it in 6 quarters since.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on NKCFO LLC's 13F filing for Q2 2026, filed 13 Aug 2026.